Cogent Biosciences (COGT) Gains from Investment Securities (2017 - 2021)
Historic Gains from Investment Securities for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $3.7 million.
- Cogent Biosciences' Gains from Investment Securities fell 5020.37% to $3.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.7 million, marking a year-over-year decrease of 6154.5%. This contributed to the annual value of $48.9 million for FY2025, which is 4879600.0% up from last year.
- Cogent Biosciences' Gains from Investment Securities amounted to $3.7 million in Q3 2021, which was down 5020.37% from $4.1 million recorded in Q2 2021.
- In the past 5 years, Cogent Biosciences' Gains from Investment Securities ranged from a high of $7.5 million in Q3 2020 and a low of -$1000.0 during Q1 2019
- Moreover, its 5-year median value for Gains from Investment Securities was $2.5 million (2019), whereas its average is $2.4 million.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 10012.87% in 2019, then soared by 44926630.0% in 2020.
- Quarter analysis of 5 years shows Cogent Biosciences' Gains from Investment Securities stood at $3.2 million in 2017, then grew by 16.0% to $3.7 million in 2018, then tumbled by 42.16% to $2.1 million in 2019, then plummeted by 98.91% to $23000.0 in 2020, then soared by 16057.81% to $3.7 million in 2021.
- Its Gains from Investment Securities was $3.7 million in Q3 2021, compared to $4.1 million in Q2 2021 and $2.9 million in Q1 2021.